Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for the Prevention of Antibiotic Associated Acute Kidney Injury
NCT05084196Phase 3Recruiting
- Sponsor
- Rutgers University
- Start
- Jun 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in acute kidney injury (AKI), sponsored by Rutgers University. Started Jun 2023; status: recruiting.
02
Drugs
melatonin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05084196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084196.